Thought  she was going to die; Bronchospasm; Little Irritability; Drainage in Throat/Upper respiratory issue; Severe asthma like reaction; Sinus infection; Moderate Glaucoma in one eye; This spontaneous case was reported by a nurse and describes the occurrence of GLAUCOMA (Moderate Glaucoma in one eye) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product LATANOPROST for an unknown indication.    The patient's past medical history included Pneumonia in 2013 and Intraocular pressure increased. Concurrent medical conditions included Seasonal allergy.   In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started LATANOPROST (unknown route) 1 drop. In March 2021, the patient experienced GLAUCOMA (Moderate Glaucoma in one eye) (seriousness criterion medically significant). On 07-Apr-2021, the patient experienced SINUSITIS (Sinus infection). In May 2021, the patient experienced ASTHMA (Severe asthma like reaction). On an unknown date, the patient experienced FEELING ABNORMAL (Thought  she was going to die), BRONCHOSPASM (Bronchospasm), EYE IRRITATION (Little Irritability) and OROPHARYNGEAL DISCOMFORT (Drainage in Throat/Upper respiratory issue). The patient was treated with AZITHROMYCIN (Z-PAK) for Sinus infection, at an unspecified dose and frequency; PREDNISONE for Difficulty breathing, at an unspecified dose and frequency; SALBUTAMOL (ALBUTEROL HFA) for Difficulty breathing, at an unspecified dose and frequency and AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN 12 H) for Productive cough, at an unspecified dose and frequency. At the time of the report, GLAUCOMA (Moderate Glaucoma in one eye), FEELING ABNORMAL (Thought  she was going to die), BRONCHOSPASM (Bronchospasm), EYE IRRITATION (Little Irritability), ASTHMA (Severe asthma like reaction) and OROPHARYNGEAL DISCOMFORT (Drainage in Throat/Upper respiratory issue) outcome was unknown and SINUSITIS (Sinus infection) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Like 220 systolic. On an unknown date, Chest X-ray: Lungs are normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter  Patient had productive cough, cough and couldn't breath. Reporter stated symptoms were very covid like symptoms.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Company comment: This spontaneous case concerns an 81-years-old female patient with relevant medical history of Intraocular pressure increased that was treated with LATANOPROST, who experienced the unexpected, serious (medically significant) event of Glaucoma among other non-serious events. The event occurred on an unknown date in context a dose of mRNA-1273 vaccine. It was reported that patient had productive cough, cough and couldn't breathe and he was treated with AZITHROMYCIN (Z-PAK) for Sinus infection, PREDNISONE for Difficulty breathing, SALBUTAMOL (ALBUTEROL HFA) for Difficulty breathing, and AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN 12 H). The events outcome was resolving. The medical history of Intraocular pressure increased of remains a confounder to the event's Glaucoma. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report. Events seriousness was assessed as per medical judgement and available information.; Sender's Comments: This spontaneous case concerns an 81-years-old female patient with relevant medical history of Intraocular pressure increased that was treated with LATANOPROST, who experienced the unexpected, serious (medically significant) event of Glaucoma among other non-serious events. The event occurred on an unknown date in context a dose of mRNA-1273 vaccine. It was reported that patient had productive cough, cough and couldn't breathe and he was treated with AZITHROMYCIN (Z-PAK) for Sinus infection, PREDNISONE for Difficulty breathing, SALBUTAMOL (ALBUTEROL HFA) for Difficulty breathing, and AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AUGMENTIN 12 H). The events outcome was resolving. The medical history of Intraocular pressure increased of remains a confounder to the event's Glaucoma. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report. Events seriousness was assessed as per medical judgement and available information.